Autoimmune-linked neuropathy, affecting an estimated 5-8% of the global population, primarily targets the peripheral nerves, leading to a variety of sensory and motor deficits (NINDS). The immune system mistakenly attacks healthy nerve tissues, disrupting essential nerve signaling. Unfortunately, due to subtle and varied early symptoms, diagnosis is often delayed, resulting in irreversible nerve damage and impaired quality of life. Recognizing the earliest warning signs remains one of the most significant challenges in the management and treatment of these disorders (NCBI).
Health
Conclusion Recognizing the early clues of autoimmune-linked neuropathy is critical to preventing irreversible nerve damage and improving long-term outcomes. Many symptoms—ranging from subtle sensory changes to…